MarketWatch

New Research Confirms Hb Variant Test for Sickle Cell, Gazelle(TM), Useful for Screening and Tracking Treatment Management in Remote Settings, Advancing Doctors' Abilities to ...

The MarketWatch News Department was not involved in the creation of this content. New Research Confirms Hb Variant Test for Sickle Cell, Gazelle(TM), Useful for Screening and Tracking Treatment ...
Business Insider

Researchers Find Gazelle™ Hb Variant Test Offers Accuracy and Accessibility for Newborn Sickle Cell Disease Screening and Premarital Screening for Beta Thalassemia and Sickle ...

Findings from studies in Türkiye and Ghana presented at ASCAT 19 th Annual Scientific Conference demonstrate that the Gazelle™ Hb Variant Test is an effective tool for accurate and affordable newborn ...
Business Insider

Hemex Health Receives FDA Breakthrough Device Designation for Gazelle® Hb Variant Test

PORTLAND, Ore., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Hemex Health, a medical diagnostics company focused on decentralized testing for blood-based conditions, today announced that the U.S. Food and Drug ...
News Medical

Hemex Health awarded $3 million grant to advance commercialization of Gazelle Hb Variant Test for the U.S. market

Hemex Health, a medical diagnostic device company focused on expanding healthcare access to underrepresented patient populations, announced it has been awarded a 3-year, $3 million grant from the ...
WDAF-TV

Hemex Health Awarded $3M NIH Grant to Bring Gazelle Hb Variant Test for Sickle Cell Disease to US Market

PORTLAND, Ore., March 27, 2023 (GLOBE NEWSWIRE) -- Hemex Health, a medical diagnostic device company focused on expanding healthcare access to underrepresented patient populations, announced it has ...